These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27784762)

  • 1. DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.
    Bhongir RK; Kasetty G; Papareddy P; Mörgelin M; Herwald H; Egesten A
    Biochem J; 2017 Feb; 474(3):411-425. PubMed ID: 27784762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
    Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
    Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.
    Jovic S; Linge HM; Shikhagaie MM; Olin AI; Lannefors L; Erjefält JS; Mörgelin M; Egesten A
    Mucosal Immunol; 2016 Jan; 9(1):112-23. PubMed ID: 25993443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
    J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA is an antimicrobial component of neutrophil extracellular traps.
    Halverson TW; Wilton M; Poon KK; Petri B; Lewenza S
    PLoS Pathog; 2015 Jan; 11(1):e1004593. PubMed ID: 25590621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications of Pseudomonas aeruginosa cell envelope in the cystic fibrosis airway alters interactions with immune cells.
    Hill PJ; Scordo JM; Arcos J; Kirkby SE; Wewers MD; Wozniak DJ; Torrelles JB
    Sci Rep; 2017 Jul; 7(1):4761. PubMed ID: 28684799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum.
    Bucki R; Sostarecz AG; Byfield FJ; Savage PB; Janmey PA
    J Antimicrob Chemother; 2007 Sep; 60(3):535-45. PubMed ID: 17584802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.
    Young RL; Malcolm KC; Kret JE; Caceres SM; Poch KR; Nichols DP; Taylor-Cousar JL; Saavedra MT; Randell SH; Vasil ML; Burns JL; Moskowitz SM; Nick JA
    PLoS One; 2011; 6(9):e23637. PubMed ID: 21909403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted Phosphatase and Deoxyribonuclease Are Required by Pseudomonas aeruginosa To Defend against Neutrophil Extracellular Traps.
    Wilton M; Halverson TWR; Charron-Mazenod L; Parkins MD; Lewenza S
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
    Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
    Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
    Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
    Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
    Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
    Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
    Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
    Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
    Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
    J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL; Millard RL
    Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
    Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
    Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease.
    Tucker SL; Sarr D; Rada B
    BMC Immunol; 2021 Jan; 22(1):7. PubMed ID: 33478382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.
    Bezzerri V; Avitabile C; Dechecchi MC; Lampronti I; Borgatti M; Montagner G; Cabrini G; Gambari R; Romanelli A
    J Pept Sci; 2014 Oct; 20(10):822-30. PubMed ID: 25201563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.